Beta-amyloid PET/CT to Measure Potential Therapeutic Response in AL-CA

Summary

This was a single center, prospective cohort study that is evaluating the ability of beta-amyloid dynamic PET/CT to detect potential therapeutic changes in subjects under treatment for AL-CA after one year had elapsed since their baseline beta-amyloid PET/CT. Demographic, clinical and PET imaging data were collected to characterize potential changes since their baseline scans.

Timeline

Start

2020-06-03

Primary completion

2025-07-01

Completion

2027-12-31

Drugs

Indications